Literature DB >> 22402815

Viral and bacterial aetiologies of epithelial ovarian cancer.

S Shanmughapriya1, G Senthilkumar, K Vinodhini, B C Das, N Vasanthi, K Natarajaseenivasan.   

Abstract

We sought to analyse the presence of human papillomavirus (HPV), Chlamydia trachomatis and cytomegalovirus (CMV) infection in women with epithelial ovarian carcinomas. Polymerase chain reaction (PCR)-based detection of microbial infections was carried out. A total of 39 tissue samples were analysed with consensus and type-specific primers for HPV, primers specific for the cryptic plasmid of Chlamydia and primers for glycoprotein B of CMV. The samples analysed showed 40%, 80% and 50% positivity for HPV, Chlamydia and CMV infection, respectively, in cancerous ovarian tissues. The HPV type detected was HPV 6, with its genome integrated to the host genome in case of both invasive and borderline tumours and existed episomally in healthy controls. The patients with Chlamydia (odds ratio [OR] 32; 95% confidence interval [CI] 3.33, 307.65) and CMV infection (OR 8; 95% CI 0.888, 72.10) are at significantly higher risk of development of ovarian tumours. The present study validates the theory of chronic infections and inflammation in the pathogenesis of epithelial ovarian cancer. Further seroepidemiological studies and large fresh tissue sampling may represent the real prevalence of infections among ovarian carcinoma patients. This study is the first of its kind in detecting the bacterial and viral aetiologies in the development of ovarian carcinoma among Indian women.

Entities:  

Mesh:

Year:  2012        PMID: 22402815     DOI: 10.1007/s10096-012-1570-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  38 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Human papillomavirus integration is not associated with advanced epithelial ovarian cancer in German patients.

Authors:  I B Runnebaum; S Maier; X W Tong; H E Rosenthal; V J Möbus; D G Kieback; R Kreienberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995 Jul-Aug       Impact factor: 4.254

Review 3.  Role of nitric oxide in genotoxicity: implication for carcinogenesis.

Authors:  E Felley-Bosco
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

4.  Silent oophoritis due to cytomegalovirus in a patient with advanced HIV disease.

Authors:  R Manfredi; G Alampi; S Talò; L Calza; M Tadolini; G N Martinelli; F Chiodo
Journal:  Int J STD AIDS       Date:  2000-06       Impact factor: 1.359

5.  An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).

Authors:  P E Castle; S L Hillier; L K Rabe; A Hildesheim; R Herrero; M C Bratti; M E Sherman; R D Burk; A C Rodriguez; M Alfaro; M L Hutchinson; J Morales; M Schiffman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-10       Impact factor: 4.254

6.  Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.

Authors:  Margaret M Madeleine; Tarja Anttila; Stephen M Schwartz; Pekka Saikku; Maija Leinonen; Joseph J Carter; Michelle Wurscher; Lisa G Johnson; Denise A Galloway; Janet R Daling
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

7.  Pelvic inflammatory disease and the risk of epithelial ovarian cancer.

Authors:  H A Risch; G R Howe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995 Jul-Aug       Impact factor: 4.254

8.  Altered MicroRNA expression in cervical carcinomas.

Authors:  Jeong-Won Lee; Chel Hun Choi; Jung-Joo Choi; Young-Ae Park; Seung-Jun Kim; Seung Yong Hwang; Woo Young Kim; Tae-Joong Kim; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

9.  Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions.

Authors:  Annika Idahl; Eva Lundin; Fredrik Elgh; Margaretha Jurstrand; Jens K Møller; Ingrid Marklund; Peter Lindgren; Ulrika Ottander
Journal:  Am J Obstet Gynecol       Date:  2009-09-20       Impact factor: 8.661

10.  Detection of human papillomavirus-16 in ovarian malignancy.

Authors:  Q-J Wu; M Guo; Z-M Lu; T Li; H-Z Qiao; Y Ke
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

View more
  47 in total

1.  Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.

Authors:  Britton Trabert; Tim Waterboer; Annika Idahl; Nicole Brenner; Louise A Brinton; Julia Butt; Sally B Coburn; Patricia Hartge; Katrin Hufnagel; Federica Inturrisi; Jolanta Lissowska; Alexander Mentzer; Beata Peplonska; Mark E Sherman; Gillian S Wills; Sarah C Woodhall; Michael Pawlita; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

Review 2.  The microbiome and gynaecological cancer development, prevention and therapy.

Authors:  Paweł Łaniewski; Zehra Esra Ilhan; Melissa M Herbst-Kralovetz
Journal:  Nat Rev Urol       Date:  2020-02-18       Impact factor: 14.432

Review 3.  Microbiota in cancer development and treatment.

Authors:  Muhammad Hassan Raza; Kamni Gul; Abida Arshad; Naveeda Riaz; Usman Waheed; Abdul Rauf; Fahad Aldakheel; Shatha Alduraywish; Maqbool Ur Rehman; Muhammad Abdullah; Muhammad Arshad
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-12       Impact factor: 4.553

4.  Metagenomic analysis of the microbiome of the upper reproductive tract: combating ovarian cancer through predictive, preventive, and personalized medicine.

Authors:  Xu Qin; Jianglin Zhou; Zizhuo Wang; Chenzhao Feng; Junpeng Fan; Jia Huang; Dianxing Hu; Babak Baban; Shengqi Wang; Ding Ma; Chaoyang Sun; Zhe Zhou; Gang Chen
Journal:  EPMA J       Date:  2022-06-23       Impact factor: 8.836

Review 5.  Vaginal microbiomes and ovarian cancer: a review.

Authors:  Jinyun Xu; Jing-Jie Peng; Wenqing Yang; Kun Fu; Yu Zhang
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

6.  An endometrial organoid model of interactions between Chlamydia and epithelial and immune cells.

Authors:  Lee Dolat; Raphael H Valdivia
Journal:  J Cell Sci       Date:  2021-03-08       Impact factor: 5.285

7.  Microbiome analyses of blood and tissues suggest cancer diagnostic approach.

Authors:  Gregory D Poore; Evguenia Kopylova; Qiyun Zhu; Carolina Carpenter; Serena Fraraccio; Stephen Wandro; Tomasz Kosciolek; Stefan Janssen; Jessica Metcalf; Se Jin Song; Jad Kanbar; Sandrine Miller-Montgomery; Robert Heaton; Rana Mckay; Sandip Pravin Patel; Austin D Swafford; Rob Knight
Journal:  Nature       Date:  2020-03-11       Impact factor: 49.962

Review 8.  The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.

Authors:  Laura M Chambers; Parker Bussies; Roberto Vargas; Emily Esakov; Surabhi Tewari; Ofer Reizes; Chad Michener
Journal:  Curr Oncol Rep       Date:  2021-06-14       Impact factor: 5.075

9.  The role of infectious agents in urogenital cancers.

Authors:  Kenneth Alibek; Nargis Karatayeva; Ildar Bekniyazov
Journal:  Infect Agent Cancer       Date:  2012-12-03       Impact factor: 2.965

10.  Bacteria and tumours: causative agents or opportunistic inhabitants?

Authors:  Joanne Cummins; Mark Tangney
Journal:  Infect Agent Cancer       Date:  2013-03-28       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.